Topical Chinese patent medicines for chronic musculoskeletal pain: systematic review and trial sequential analysis
Abstract Purpose Chronic musculoskeletal pain (CMP) is defined as persistent or recurrent pain that occurs in the joints, musculo-soft tissue, spine or bones for more than three months and is not completely curable. Although topical Chinese patent medicine (CPM) is the most extensively utilized medi...
Main Authors: | Kaiqiang Tang, Jigao Sun, Yawei Dong, Zelu Zheng, Rongtian Wang, Na Lin, Weiheng Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-12-01
|
Series: | BMC Musculoskeletal Disorders |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12891-023-07072-8 |
Similar Items
-
The reporting checklist for Chinese patent medicine guidelines: RIGHT for CPM
by: Xuanlin Li, et al.
Published: (2024-01-01) -
Comparative efficacy of Chinese patent medicines in patients with carotid atherosclerotic plaque: a Bayesian network meta− analysis
by: Wenquan Su, et al.
Published: (2023-11-01) -
Internationalization of Traditional/Complementary Medicine products: market entry as medicine
by: Jiatong Li, et al.
Published: (2018-10-01) -
The Chinese patent medicine Tongfengding capsule for gout in adults: a systematic review of safety and effectiveness
by: Qiaoli Hua, et al.
Published: (2023-07-01) -
Clinical practice guideline on traditional Chinese medicine in the treatment of influenza (2021)
by: Qingquan Liu, et al.
Published: (2021-10-01)